The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors

Overview of attention for article published in Experimental Hematology & Oncology, November 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 31 publications that cite this research output.

31

The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.

Dietary silymarin improves performance by altering hepatic lipid metabolism and intestinal microbiota function and its metabolites in late laying hens

Preprint in Research Square (March 2024)

Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23

Article in Human Vaccines & Immunotherapeutics (December 2023)

Autologous CIK cells combined with chemotherapy as the first-line treatment for locally advanced or metastatic gastric cancer is safe and feasible

Article in Frontiers in Immunology (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.